Health Condition 1: K87- Disorders of gallbladder, biliarytract and pancreas in diseases classified elsewhere Health Condition 2: K566- Other and unspecified intestinal obstruction
Conditions
Interventions
Intervention1: Group Lignocaine ( Group L): Patients allotted to lignocaine (group L) will receive bolus dose of lignocaine 1.5 mg/kg through a dedicated intravenous line followed by an infusion@ 1.5m
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: Patients in age groups 18- 70 Healthy patients belonging to ASA PS I and II Patients undergoing elective upper abdominal surgery.
Exclusion criteria
Exclusion criteria: Inability to understand preoperative instructions regarding use of PCA pump or pain score Planned elective postoperative mechanical ventilation Patients known to be on anti-arrhythmic drug therapy History of COPD, cardiac, hepatic, renal or nervous system disorder Known allergy to lignocaine
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| TIME INTERVAL between skin closure and first morphine PCA request. TOTAL MORPHINE CONSUMPTION at the end of 2nd, 6th, 12th, 24th and 36th postoperative hour. Timepoint: Immediate postoperative period 36 hours after surgery | — |
Secondary
| Measure | Time frame |
|---|---|
| PAIN SCORE (NRS) at rest, on deep inspiration, cough and movement (side to side or leg raising) at the end of 2nd, 6th, 12th, 24th and 36th postoperative hour. Any complaints of â??perioral numbness, light headedness. Sedation level Timepoint: Immediate postoperative period 36 hours after surgery | — |
Countries
India
Contacts
Public ContactDr Lokvendra Singh Budania
Kasturba Medical College, Manipal, Manipal Academy Of Higher Education
Outcome results
None listed